RMT Set For The Promotion And Sale Of The ADAM Mobile Robots

RMT Robotics®, a Cimcorp Oy company and the manufacturer and integrator of ADAM™ autonomous mobile robot (AMR), has entered into a sales representative agreement with MIBA for the promotion and sale of its ADAM mobile robots in Italy.


MIBA, through its eepos Italy division, will work with RMT to promote and sell the AMR solutions to end users throughout Italy and southern Europe with a strategic focus on applications in manufacturing industries such as original equipment (OE) as well as tier 1 and 2 automotive, electronics, plastics and aerospace.

ADAM autonomous mobile robot (AMR). Credit: Koroberi.com


“We are thrilled to work with MIBA, through its eepos Italy division, to bring the ADAM system to manufacturers in southern Europe,” said Bill Torrens, director of ADAM Systems Group, RMT Robotics. “Their experience and connections in the Italian industrial marketplace make MIBA an ideal addition to ADAM’s growing global network of promotional partners.”


“The ADAM AMR system is a unique and innovative solution that has great potential to transform the way materials are transported in Italian factories,” said Adolfo Lorenzi, principal, MIBA. “We are eager to work with RMT to introduce ADAM and promote the many benefits to our customers.”


ADAM Autonomous Mobile Robots


ADAM is an AMR that independently performs random origin to random destination transport of work-in-process materials and finished goods in lean manufacturing and assembly applications. ADAM is designed to perform missions autonomously, navigating around fixed and moving objects, free of guide wires, reflectors or transponders.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.